Loss of mtSIRT3, Decreased MnSOD Activity, and IR Induced Genomic Instability
Loss of mtSIRT3, Decreased MnSOD Activity, and IR Induced Genomic Instability
批准号:
8408793
负责人:
David Gius
金额:
$36.77万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-07 至 2014-12-31
关键词:
AcetylationArginineAsparagineBiochemicalBiologicalBiological ModelsBiologyCell NucleusCell physiologyCellsCytosolDataDeacetylaseDeacetylationDuctalEventExhibitsExposure toFastingGene MutationGenesGenomic InstabilityGenotoxic StressGlutamineGoalsHumanIn VitroInfectionIonizing radiationKnock-outKnockout MiceLaboratoriesLinkLysineMYC geneMalignant NeoplasmsMammalian CellMammary NeoplasmsManganese Superoxide DismutaseMetabolismMitochondriaMitochondrial ProteinsModificationMolecularMusNuclearPhenotypePlayPost-Translational Protein ProcessingProductionProteinsRadiationRadiation induced damageRadiation-Induced CancerRegulationResveratrolRoleSecondary toSeriesSignal TransductionSiteStaining methodStainsStimulusSubfamily lentivirinaeSuperoxide DismutaseSuperoxidesSuppressor-Effector T-LymphocytesTranslatingTranslationsTumor Suppressor ProteinsWorkbasecarcinogenesiscell injuryextracellularin vivoin vivo Modelloss of functionmutantpreventpublic health relevanceresearch studyresponsetissue culturetumortumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Nuclear genome instability, a hallmark of cancer, is thought to be an early event in tumorigenesis including malignancies induced from IR either from incidental exposure or secondary to therapy. It is well established that mammalian cells contain fidelity proteins that appear to protect against both endogenous and exogenous forms of genotoxic stress including ionizing radiation (IR)-induced genomic instability. This idea is based on one of the fundamental paradigms in biology: that is mammalian cells contain fidelity proteins that recognize specific conditions, including cell damage, and subsequently initiate signaling cascades that maintain cellular homeostatic poise. In addition, loss of function or genetic mutation of these fidelity proteins has been shown to create tumor permissive cellular phenotype suggesting that these proteins also function as tumors suppressors (TS). Preliminary data in our laboratory suggests that SIRT3, which is a genomically expressed, mitochondrial localized protein, is TS and cells lacking SIRT3 exhibit increased IR- induced genomic instability. Thus, the overarching goal of this proposal is to determine a mechanistic connection between SIRT3, mitochondrial metabolism, specifically superoxide levels, and IR genomic instability as well as IR-induced cancers. In this proposal we hypothesize that SIRT3 protects against IR-induced genomic instability and carcinogenesis via the regulation of MnSOD activity and the post translation modification of a reversible acetyl lysine. In addition, we are also proposing that lysine acetylation may be a primary posttranslational modification employed to regulate mitochondrial proteins. To investigate a mechanistic connection between SIRT3, MnSOD, and IR-induced genomic instability a series of in vitro and in vivo model systems will be used.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy
-
批准号:10737810
-
项目类别:
-
资助金额:$6.81万
-
财政年份:2021
-
负责人:David Gius
-
依托单位:
Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy
-
批准号:10533472
-
项目类别:
-
资助金额:$6.95万
-
财政年份:2021
-
负责人:David Gius
-
依托单位:
Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy
-
批准号:10390451
-
项目类别:
-
资助金额:$37.61万
-
财政年份:2021
-
负责人:David Gius
-
依托单位:
MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies
-
批准号:10327336
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2021
-
负责人:David Gius
-
依托单位:
MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies.
-
批准号:10817556
-
项目类别:
-
资助金额:$5.07万
-
财政年份:2021
-
负责人:David Gius
-
依托单位:
Dys-regulation of the MnSOD-Ac-ROS-HIF2a axis promotes IR / Cisplatin resistance phenotype
-
批准号:10335424
-
项目类别:
-
资助金额:$38.95万
-
财政年份:2021
-
负责人:David Gius
-
依托单位:
MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies
-
批准号:10541193
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2021
-
负责人:David Gius
-
依托单位:
Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy
-
批准号:10548835
-
项目类别:
-
资助金额:$37.61万
-
财政年份:2021
-
负责人:David Gius
-
依托单位:
Dys-regulation of the MnSOD-Ac-ROS-HIF2a axis promotes IR / Cisplatin resistance phenotype
-
批准号:10024964
-
项目类别:
-
资助金额:$7.28万
-
财政年份:2017
-
负责人:David Gius
-
依托单位:
Dys-regulation of the MnSOD-Ac-ROS-HIF2a axis promotes IR / Cisplatin resistance phenotype
-
批准号:9889066
-
项目类别:
-
资助金额:$39.02万
-
财政年份:2017
-
负责人:David Gius
-
依托单位:
Dys-regulation of the MnSOD-Ac-ROS-HIF2a axis promotes IR / Cisplatin resistance phenotype
-
批准号:9262705
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2017
-
负责人:David Gius
-
依托单位:
ROS and HIFa as molecular targets for chemoprevention in Sirt3 -/- breast cancers
-
批准号:8401029
-
项目类别:
-
资助金额:$37.96万
-
财政年份:2012
-
负责人:David Gius
-
依托单位:
ROS and HIFa as molecular targets for chemoprevention in Sirt3 -/- breast cancers
-
批准号:8549177
-
项目类别:
-
资助金额:$35.68万
-
财政年份:2012
-
负责人:David Gius
-
依托单位:
ROS and HIFa as molecular targets for chemoprevention in Sirt3 -/- breast cancers
-
批准号:8704896
-
项目类别:
-
资助金额:$36.82万
-
财政年份:2012
-
负责人:David Gius
-
依托单位:
ROS and HIFa as molecular targets for chemoprevention in Sirt3 -/- breast cancers
-
批准号:8890802
-
项目类别:
-
资助金额:$37.96万
-
财政年份:2012
-
负责人:David Gius
-
依托单位:
ROS and HIFa as molecular targets for chemoprevention in Sirt3 -/- breast cancers
-
批准号:9114533
-
项目类别:
-
资助金额:$37.96万
-
财政年份:2012
-
负责人:David Gius
-
依托单位:
SIRT3 is a Mitochondrial Tumor Suppressor in ER/PR Positive Mammary Tumors
-
批准号:8547783
-
项目类别:
-
资助金额:$29.77万
-
财政年份:2011
-
负责人:David Gius
-
依托单位:
SIRT3 is a Mitochondrial Tumor Suppressor in ER/PR Positive Mammary Tumors
-
批准号:8703629
-
项目类别:
-
资助金额:$30.67万
-
财政年份:2011
-
负责人:David Gius
-
依托单位:
SIRT3 is a Mitochondrial Tumor Suppressor in ER/PR Positive Mammary Tumors
-
批准号:8050512
-
项目类别:
-
资助金额:$32.32万
-
财政年份:2011
-
负责人:David Gius
-
依托单位:
Loss of Mitochondrial Sirt3, Decreased MnSOD Activity, and IR Induced Genomic Instability
-
批准号:8914122
-
项目类别:
-
资助金额:$36.27万
-
财政年份:2010
-
负责人:David Gius
-
依托单位:
国内基金
海外基金
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位: